An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
Abstract Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes targeted by RSV-neutralizing antibodies are...
Guardado en:
Autores principales: | Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle, John A. Robinson, Arin Ghasparian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adb559966dc64ff4b26148413e229c01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021) -
CYTOKINE PROFILE IN ADULTS WITH RESPIRATORY SYNCYTIAL VIRAL INFECTION
por: I. A. Klimova, et al.
Publicado: (2018) -
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
por: Milad Zandi, et al.
Publicado: (2021) -
Immune response to respiratory syncytial virus infection (<i>Orthopneumovirus</i>)
por: A. A. Nikonova, et al.
Publicado: (2021) -
Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells.
por: Srikanth Elesela, et al.
Publicado: (2020)